Humana (NYSE:HUM) Lowered to Equal Weight at Stephens

Stephens lowered shares of Humana (NYSE:HUM) from an overweight rating to an equal weight rating in a report released on Wednesday, Marketbeat.com reports. The firm currently has $250.00 price target on the insurance provider’s stock, down from their prior price target of $400.00.

A number of other equities analysts have also recently weighed in on HUM. TD Cowen raised their price objective on Humana from $396.00 to $407.00 and gave the company a buy rating in a report on Wednesday, July 24th. Cantor Fitzgerald reissued a neutral rating and set a $395.00 price target on shares of Humana in a research note on Tuesday, October 1st. Truist Financial boosted their price objective on shares of Humana from $355.00 to $400.00 and gave the stock a hold rating in a report on Monday, July 15th. Piper Sandler assumed coverage on shares of Humana in a report on Wednesday, June 26th. They set an overweight rating and a $392.00 target price on the stock. Finally, Royal Bank of Canada boosted their price target on shares of Humana from $385.00 to $400.00 and gave the stock an outperform rating in a research note on Thursday, September 5th. One equities research analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of Hold and an average target price of $357.24.

Humana Price Performance

HUM stock opened at $240.03 on Wednesday. The firm has a 50 day simple moving average of $337.70 and a two-hundred day simple moving average of $342.66. The stock has a market cap of $28.92 billion, a PE ratio of 14.95, a P/E/G ratio of 2.44 and a beta of 0.50. Humana has a one year low of $213.31 and a one year high of $530.54. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. The company had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $8.94 EPS. On average, analysts predict that Humana will post 16.01 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be issued a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.47%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Institutional Investors Weigh In On Humana

A number of large investors have recently modified their holdings of HUM. Mendota Financial Group LLC grew its holdings in shares of Humana by 9.2% during the 2nd quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 27 shares during the period. Aurora Investment Counsel boosted its holdings in shares of Humana by 1.3% during the 4th quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock valued at $1,155,000 after buying an additional 29 shares in the last quarter. Capital Advisors Ltd. LLC grew its position in shares of Humana by 17.0% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after buying an additional 31 shares during the period. EP Wealth Advisors LLC increased its stake in shares of Humana by 1.6% in the 4th quarter. EP Wealth Advisors LLC now owns 2,294 shares of the insurance provider’s stock worth $1,050,000 after acquiring an additional 37 shares in the last quarter. Finally, CarsonAllaria Wealth Management Ltd. lifted its position in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.